Predictive Oncology Inc. (POAI) has 14 open-market insider trades by 6 insiders since 2019. The most active filer is Richard L. Gabriel, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Charles Lee Nuzum Sr. | Dir | — | 2 | $92K | 2025-09-09 |
| J. Melville Engle | Dir | — | 1 | $59K | 2022-11-01 |
| Richard L. Gabriel | Dir | — | 4 | $10K | 2021-04-01 |
| Robert L. Myers | CFO | — | 2 | $10K | 2023-09-25 |
| Daniel E. Handley | Dir | — | 4 | $8K | 2025-09-09 |
| Raymond F. Vennare | CEO | — | 1 | $3K | 2025-11-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Charles Lee Nuzum Sr. | Director | Sell | $30K | 2023-09-25 |
| Daniel E. Handley | Director | Buy | $2K | 2022-12-15 |
| Raymond F. Vennare | Director | Buy | $3K | 2022-12-02 |
| Robert L. Myers | CFO | Buy | $5K | 2022-12-02 |
| Daniel E. Handley | Director | Buy | $4K | 2022-11-29 |
| Daniel E. Handley | Director | Buy | $944 | 2022-05-26 |
Companies that share insiders with POAI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Daniel E. Handley | Director | Buy | $980 | 2022-05-25 |
| J. Melville Engle | Director | Buy | $59K | 2022-05-24 |
| Charles Lee Nuzum Sr. | Director | Buy | $62K | 2022-05-20 |
| Robert L. Myers | CFO | Buy | $5K | 2022-05-20 |
| Carl I. Schwartz | CEO & 10% | Sell | $544 | 2020-10-22 |
| Richard L. Gabriel | Director | Buy | $4K | 2020-09-01 |
| Richard L. Gabriel | Director | Buy | $4K | 2020-08-19 |
| Richard L. Gabriel | Director | Buy | $920 | 2019-09-05 |
| Richard L. Gabriel | Director | Buy | $2K | 2019-08-23 |